Our data revealed that rhodomycin A inhibits FAK, JNK, Paxillin, and p130cas activity and the protein expression in PC9 and PC9/gef cell lines, which may cause the decrease of cancer cell invasion and migration ability. The gene discussed is BCAR1; the disease is cancer.